StockData
Valion Bio, Inc. logo

Valion Bio, Inc. (VBIO) stock

VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.50−0.04 (-7.55%)

Close on Nov 18, 2026Market cap $2.09MP/E –Yield –

Valion Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Valion Bio's revenue for the twelve months ending Sep 30, 2025 was $482.00K, down 49.6% year over year. For fiscal 2024 it was $780.00K, down 33.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$780.00K-33.7%
FY2023Dec 31, 2023$1.18M-36.1%
FY2022Dec 31, 2022$1.84M+46.4%
FY2021Dec 31, 2021$1.26M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$146.00K+15.9%
Q2 FY2025Jun 30, 2025$86.00K-38.6%
Q1 FY2025Mar 31, 2025$70.00K-79.0%
Q4 FY2024Dec 31, 2024$180.00K-49.6%
Q3 FY2024Sep 30, 2024$126.00K-55.3%
Q2 FY2024Jun 30, 2024$140.00K-13.0%
Q1 FY2024Mar 31, 2024$334.00K-11.2%
Q4 FY2023Dec 31, 2023$357.00K-12.5%
Q3 FY2023Sep 30, 2023$282.00K-40.9%
Q2 FY2023Jun 30, 2023$161.00K-69.5%
Q1 FY2023Mar 31, 2023$376.00K-12.1%
Q4 FY2022Dec 31, 2022$408.00K+4.9%
Q3 FY2022Sep 30, 2022$477.00K+72.2%
Q2 FY2022Jun 30, 2022$528.00K+97.0%
Q1 FY2022Mar 31, 2022$428.00K+32.5%
Q4 FY2021Dec 31, 2021$389.00K–
Q3 FY2021Sep 30, 2021$277.00K–
Q2 FY2021Jun 30, 2021$268.00K–
Q1 FY2021Mar 31, 2021$323.00K–

More Valion Bio figures

See a number that looks wrong?